Abnormal Uterine Bleeding

DBCOND0039070Cardiovascular DiseasesHemic and Lymphatic Diseases

Abnormal Uterine Bleeding is the indication for 7 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as
Dysfunctional Uterine Bleeding · Abnormal Uterine Bleeding, Unspecified · Dysfunction Uterine Bleeding · irregular intrauterine bleeding · uterine bleeding irregularities
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT640340ICD-10N92.1SNOMED CT156039005MedDRA10005120UMLSC0025874

What you can answer from here — as of October 31, 2026

7Indicated drugsWith each drug's targets and mechanism
Listed above
7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
31Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Abnormal Uterine Bleeding share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In